Xeomin (Incobotulinumtoxin-A)
Xeomin (Incobotulinumtoxin-A), produced by Merz Aesthetics (Germany), containing the active substance botulinum toxin type A, purified from the complex protein structure (pure neurotoxin); It is a neuromuscular blocking injection treatment that was approved by the FDA in 2011 for aesthetic glabellar lines and is known for its low immunogenicity profile.
Core Term · 3,884 words